Table A1.
Study/ Registry |
Echinacea Species | Control | Extraction Method | Supplement | Duration of Treatment/Observation | Daily Dose/Amount of Echinacea [mg] | Participant Number (N, ITT) | Age [Years] | Cold Definition | Jadad Score [18] |
---|---|---|---|---|---|---|---|---|---|---|
Bendel R et al., 1988 [20] | EPAr + EPUr Esberitox | NT | Ethanolic Extract | Thuiae occid, Baptisia | 50 days in addition to Chemotherapy Prevention |
3 × 50 drops | 50 | >18 | Respiratory Infection induced Stop of Chemotherapy medically confirmed | 2 |
Bendel R et al., 1989 [19] | EPAr + EPUr Esberitox | NT | Ethanolic Extract | Thuiae occid, Baptisia | 12 Chemotherapy Cycles à 14 days Prevention |
3 × 25 drops | 67 | >18 | Respiratory Infection induced Stop of Chemotherapy medically confirmed | 1 |
Bräuning B et al., 1992 [36] | EPUr | Placebo | Ethanolic Extract | None | Therapy 8–10 days | Dosis 1 = 90 drops/450 mg Dosis 2 = 2 × 90 drops/900 mg |
180 | 18–60 | Flu-like Infections, clinically confirmed (virally vs. bacterial) | 1 |
Cohen HA et al., 2004 [18] | EPU + EAN | Placebo | Glycerol extract | Propolis + Vitamin C | 3 mts Prevention |
2–4 × 5–7.5 mL 500–1500 mg | 328 | 1–5 | Patient reported- medically confirmed |
4 |
Forth H, Beuscher N, 1981 [17] | EPAr + EPUr (Esberitox) | Placebo (20 mg Vit C) | Ethanolic extract | Thuiae occid, Baptisia | 3 × 14d cycles for up to 17 weeks Prevention |
3 × 25 drops or 3 × 1 tablet | 95 | >18 | Patient reported Rhinitis | 1 |
Freyer HU, 1974 [22] | EPAr + EPUr | NT | Ethanolic extract | Thujae occid, Baptisia | 6 weeks Prevention |
3 × 20 drops | 284 | 6–17 | “infections” not further described | 1 |
Goel V et al., 2004 [38] | EPU | Placebo | Ethanol | None | 7 days Therapy |
1st day: 10 × 4 mL 6 days: 4 × 4 mL |
128 ≥2 colds/y |
18–65 | Patient reported Confirmed by study nurse/physician | 5 |
Grimm (1999)/Schoeneberger (1996) [23,62] | EPUh | Placebo | Pressed-juice | None | 2 mts Prevention |
2 × 4 mL 6200 mg 2) |
108 ≥3 colds/y |
>11 | Patient reported- Confirmed by physician |
5 |
Hall, H et al., 2007 [24] | EPUh | Placebo | Pressed Juice | none | 28 days Prevention |
4 × 2 capsules/8000 mg | 32 | >17 | Incidence of URTI Patient-reported outcome | 4 |
Helbig (1961) [25] | EPUr + EANr (Esberitox) | NT | Ethanolic extract | Thujae occid/Baptisia | 1 mt Prevention |
3 × 20 drops | 644 | 1–3 | Infections of Upper Respiratory Tract | 0 |
Jawad et al., 2012 [26] | EPU h + r (Echinaforce) | Placebo | Ethanolic extract | None | 4 mts Prevention |
3–5 × 0.9 mL 2.7–4.5 mL 2400–4000 mg |
717 | >17 | Patient reported–confirmed by Jackson method Virally confirmed infections |
5 |
König D, 1999 or Berg A (1998) [21] | EPUh | Placebo/Magnesium | Pressed Juice i.c. placebo and Biomagnesin |
None | 28 days Prevention |
3 × 40 drops/8000 mg | 42 (Athletes) | >17 | Incidence of URTI Infection, Training failures | 3 |
Kolev E et al., 2022 [27] | EPU h + r (Echinaforce) | NT | Ethanolic extract | None | 5 months Prevention |
3–5 × 2 tablets (400 mg)/2400–4000 mg | 119 | 18–75 | Patient reported, physician and virally-confirmed infections | 2 |
Melchart (1998) 3-arm study [15] |
EPUr | Placebo | Ethanolic extract | None | 3 mts Prevention |
2 × 50 drops 1800 mg 3) |
99 (90 placebo) =/>3 colds/y |
18–65 | Patient reported- Confirmed by physician |
4 |
Melchart (1998) 3-arm study [15] |
EANr | Ethanolic extract | None | 3 mts Prevention |
2 × 50 drops 1800 mg 3) |
100 (90 placebo) |
18–65 | Patient reported- Confirmed by physician |
||
O’Neil J et al., 2008 [28] | EPU | Placebo | Dried Echinacea, not specified | None | 8 weeks Prevention |
3 × 2 capsules/1800 mg | 90 | 18–65 | Patient reported- Study staff confirmed |
4 |
Ogal M et al., 2021 NCT02971384 [14] |
EPU h + r (Echinaforce) | Placebo (VitC) | Ethanolic extract | None | 4 months Prevention |
3–5 × 1 tablet (400 mg)/1200–2000 mg | 203 | 4–12 | Patient reported, physician and virally-confirmed infections | 5 |
Awad OG, 2020 2015NBA5732814 [29] |
EPU root | Azithromycin (AZT) vs. NTC | Powder | None | 6 × 10 days over 6 months Prevention |
3 × 5 mL (250 mg)/1500 mg + AZT I.c. no prevention/ATZ prevention |
300 | 5–16 | Recurrent tonsillitis, reported by parents | 1 |
Schmidt U et al., 1990 [30] | EAN | Placebo | Ethanolic extract | Eupatorium/Baptisia | 2 month Prevention |
1 × 12 mL/1440 mg 1) | 609 | >17 | Patient reported- Confirmed by physician |
4 |
Schulten B et al., 2001 [40] | EPUh (Echinacin®) |
Placebo | Pressed Juice | None | 10 days Therapy |
2 × 5 mL (7750 mg) | 80 | >17 | Patient reported confirmed by Jackson method (full picture of cold) | 3 |
Spasov AA et al., 2004 [41] | EPUh | NT (standard therapy) | Pressed Juice | None (i.a. std treatment) | 10 days Therapy |
3 × 10 drops | 80 | 4–11 | Patient reported, Physician confirmed uncomplicated RTIs | 2 |
Sperber SJ et al., 2004 [31] | EPUh Echinaguard |
Placebo | Pressed juice | None | 14d Prevention |
3 × 2.5 mL | 46 | 18–65 | Artificially Rhinovirus Infection, Jackson definition | 3 |
Sumer J et al., 2023 [37] | EPU (h + r) (Echinaforce) |
Ethanolic extract | None | 10 days Therapy |
1–5 tablets (3360 mg) or 2–7 sprays (1120 mg) 3360–16,800 mg |
246 | >17 | Patient reported, physician and virally-confirmed flu-like infections | 4 | |
Tiralongo E et al., 2012 [32] | EPUr + EANr (MediHerb) | Placebo | Ethanolic extract | None | 5–9 weeks Prevention |
Priming dose 2 × 1 tabs followed by exposition dose 2 × 2 tabs sick dose 3 × 2 tabs/3825 mg and 7650 mg | 148 | 18–65 | Natural exposition (air travel) | 5 |
Turner RB et al., 2005 [16] 4-arm study |
EANr | Placebo | 20% Ethanolic extract | None | 7 days Prevention 5 days Therapy |
3 × 1.5 mL (300 mg)/900 mg | 206 | >17 | Artificially Rhinovirus Infection, Jackson definition Patient reported, physician and virally-confirmed flu-like infections |
4 |
Turner RB et al., 2005 [16] 4-arm study |
EANr | Placebo | 60% Ethanolic extract | None | 7 days Prevention 5 days Therapy |
3 × 1.5 mL (300 mg)/900 mg | 203 | >17 | 4 | |
Turner RB et al., 2005 [16] 4-arm study |
EANr | Placebo | CO2 extract | None | 7 days Prevention 5 days Therapy |
3 × 1.5 mL (300 mg)/900 mg | 196 | >17 | 4 | |
Turner RB et al., 2000 [33] | EPU | Placebo | Powder Almost no alkylamides |
None | 19 days (14 days prevention + 5 days therapy) Prevention |
3 × 1 capsule/900 mg | 92 | >17 | Artificial Rhinovirus Infection, | 3 |
Taylor (2003)/Weber (2005) [35,42] | EPUh (Echinacin®) | Placebo | Pressed juice | None- | 4/1 week Therapy |
2 × 3.75–5 mL 7.5–10 mL 7500–10,000 mg |
407/401 | 2–11 | Study staff confirmed | 5 |
Yakoot M et al., 2011 [43] | E (Immumax) |
Placebo | Extract | Garlic, Nigella sativa, Panax ginseng, Vitamin C, Zinc | 14 days Therapy |
2 × 1 capsule (120 mg)/240 mg | 63 | 38 (Mean) | Patient reported- Confirmed by physician |
5 |
Zhang X et al., 2003 [34] | EPUr | Placebo | Powdered root | None | 8 weeks Prevention |
2 × 1 capsule (294 mg)/588 mg | 111 | 18–65 | Patient reported- Confirmed by physician |
3 |
E…Echinacea (not further specified) EAN…Echinacea angustifolia. EPU…Echinacea purpurea. h…herb. r…root. NT…No-treatment control. ITT…Intention-to-treat. 1) with 120 mg/mL EA extract; 2) product contains 22% Ethanol for stabilisation; 3) at 20 drops / ml and δ = 0.9 gr/mL.